Efficacy and Safety Outcomes with Pembrolizumab (Pembro) Rechallenge for Patients (Pts) with Advanced/Metastatic Urothelial Cancer (UC) Who Responded To First-Course Treatment

Koshkin, V. S.Danchaivijitr, P.Bae, W. K.Semenov, A.Ozyilkan, O.Su, Y-L.Arranz Arija, J. A.Tsujihata, M.Boegemann, M.Hendriks, M. P.Neciosup Delgado, S. P.Cheng, S.Rosenbaum, E.Lopez, K.Bavle, A.Liu, C-C.Imai, K.Furka, A.2024-05-172024-05-1720230923-7534http://hdl.handle.net/11727/12119enginfo:eu-repo/semantics/closedAccessEfficacy and Safety Outcomes with Pembrolizumab (Pembro) Rechallenge for Patients (Pts) with Advanced/Metastatic Urothelial Cancer (UC) Who Responded To First-Course TreatmentconferenceObject34Supplement 2S1211S12110010874802033731569-8041